Login / Signup

Regenerative Medicine in Urogynecology: Where We Are and Where We Want to Be.

Tatyanna HendersonKaren L ChristmanMarianna Alperin
Published in: Urogynecology (Philadelphia, Pa.) (2024)
Pelvic floor disorders (PFDs) constitute a major public health issue given their negative effect on quality of life for millions of women worldwide and the associated economic burden. As the prevalence of PFDs continues to increase, novel therapeutic approaches for the effective treatment of these disorders are urgently needed. Regenerative medicine techniques, including cellular therapies, extracellular vesicles, secretomes, platelet-rich plasma, laser therapy, and bioinductive acellular biomaterial scaffolds, are emerging as viable clinical options to counteract urinary and fecal incontinence, as well as pelvic organ prolapse. This brief expert review explores the current state-of-science regarding application of these therapies for the treatment of PFDs. Although regenerative approaches have not been widely deployed in clinical care to date, these innovative techniques show a promising safety profile and potential to positively affect the quality of life of patients with PFDs. Furthermore, investigations focused on regeneration of the main constituents of the pelvic floor and lower urinary tract improve our understanding of the underlying pathophysiology of PFDs. Regenerative medicine techniques have a high potential not only to revolutionize treatment of PFDs but also to prevent these complex conditions.
Keyphrases
  • public health
  • stem cells
  • platelet rich plasma
  • palliative care
  • polycystic ovary syndrome
  • urinary tract
  • risk assessment
  • risk factors
  • pain management
  • metabolic syndrome
  • quality improvement
  • chronic pain
  • cell therapy